Trupanion (TRUP) Profitability Turn And 41x P/E Test Bullish Earnings Narratives
Trupanion, Inc. TRUP | 0.00 |
Trupanion (TRUP) opened 2026 with Q1 revenue of US$384.0 million and basic EPS of US$0.11, alongside trailing twelve month revenue of US$1.5b and EPS of US$0.60 that reflect its recent shift into profitability. Over the past reported quarters, revenue moved from US$342.0 million and EPS of US$0.03 in Q4 2024 to US$384.0 million and US$0.11 respectively in Q1 2026. Trailing net income also shifted from a loss of US$9.6 million in Q4 2024 to a profit of US$25.8 million in Q1 2026. With that backdrop, the latest quarter points to firmer margins and a business that is now earning its way forward rather than relying on one off gains.
See our full analysis for Trupanion.With the numbers on the table, the next step is to see how this earnings profile lines up with the prevailing growth and risk narratives that investors have been watching.
Profitability now positive on a 12 month basis
- On a trailing 12 month view, net income moved from a loss of US$9.6 million in Q4 2024 to a profit of US$25.8 million in Q1 2026, with basic EPS over that period at US$0.60.
- Supporters of the bullish narrative point to this profitability shift alongside forecast earnings growth of about 19% per year as evidence that earnings can compound from a stronger base, yet the presence of a US$6.7 million one off gain in the last 12 months means part of that earnings profile is tied to non recurring items rather than purely ongoing operations.
- Consensus commentary highlights that the company only became profitable over the past year, so the US$25.8 million trailing net income is still in an early phase and sensitive to items like that US$6.7 million gain.
- Bulls argue that improving margins and positive EPS put the business on a firmer footing, but anyone relying on the 19% earnings growth outlook has to keep in mind that the recent 12 month base includes that one off contribution.
Bulls point to Trupanion’s profitability turn and forecast earnings growth as a long term inflection for the business, and the full bullish narrative sets out how they think those trends could continue from here 🐂 Trupanion Bull Case
Quarterly EPS steady while forecasts stay ambitious
- Across the last four reported quarters, basic EPS moved from a loss of US$0.03 in Q1 2025 to positive readings of US$0.22, US$0.14, US$0.13 and US$0.11, while trailing 12 month EPS reached US$0.60 by Q1 2026.
- Analysts who are cautious flag that, even with this positive streak, the latest single quarter EPS of US$0.11 and net income of US$4.9 million sit below some prior quarters, which they see as a constraint on the more optimistic forecasts that call for earnings to reach US$33.6 million or US$31.9 million in future years.
- Bears highlight that the bullish and consensus paths both expect earnings in the tens of millions, yet the most recent quarterly run rate, at US$4.9 million of net income, is still some distance from those figures.
- This mix of positive but relatively modest quarterly profits and ambitious multi year earnings targets is central to the bearish concern that future growth assumptions may be too demanding if quarterly performance does not accelerate meaningfully.
Skeptical investors focus on the gap between current quarterly profits and ambitious multi year earnings targets, and the bearish narrative sets out how that gap could become a problem if growth underwhelms 🐻 Trupanion Bear Case
P/E of 41x prices in strong growth
- The shares trade on a P/E of about 41x based on trailing earnings, compared with an average of 11.7x for the US insurance industry and 8.5x for peers, while the current share price sits at US$24.33 against an analyst target level of US$40.50.
- What stands out in the consensus narrative is that this valuation premium is paired with forecast revenue growth of 7.7% per year, which is below the 11% figure cited for the wider US market, even though earnings growth is forecast to be faster. That creates a tension between paying up for earnings expansion and accepting more modest top line growth.
- Critics point out that a 41x P/E and forecasts of 8.5% to 10.1% annual revenue growth rely heavily on margin progress and profit conversion rather than very rapid sales growth compared with the broader market.
- Supporters counter that the move from a trailing loss of US$9.6 million to a profit of US$25.8 million, along with the positive EPS trend over the last few quarters, justifies some premium while forecasts call for earnings to grow faster than the reference US market earnings rate of about 15.8% per year.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Trupanion on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With bulls and bears pulling in different directions on Trupanion, this is a moment to look through the numbers yourself and reach an informed view without waiting on the crowd. To help with that, it is worth weighing the 2 key rewards and 2 important warning signs.
See What Else Is Out There
Trupanion’s rich 41x P/E, modest forecast revenue growth and reliance on early stage profitability leave limited room for error if expectations tighten.
If that mix of high expectations and execution risk feels uncomfortable, you can quickly compare it with companies that screen as more resilient by balance sheet and fundamentals using the solid balance sheet and fundamentals stocks screener (44 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
